-
Mag-Sup powder – a better way to absorb magnesium
Wednesday | Oct 29 2025MAG-SUP powder is a high absorption magnesium supplement for use in magnesium deficiencies. It contains magnesium aspartate which has increased bioavailability compared to other forms of magnesium. Magnesium aspartate has better oral absorption than magnesium citrate, magnesium glycinate, magnesium chloride and magnesium oxide.
-
PD for Wed 29 Oct 2025
Wednesday | Oct 29 2025Peak bodies join on pharmacist prescribing submission, med cannabis driving defence needed now, heatwaves worsen sleep apnoea, and more
-
Guild welcomes expanded optometrist prescribing
Tuesday | Oct 28 2025A PROPOSAL by the Optometry Board of Australia to change prescribing rules for optometrists could see them prescribing oral medicines from an approved list to treat potentially sight-threatening eye conditions, bacterial eye infections, eye allergies and short-term eye pain.
-
Could COVID vax fight cancer?
Tuesday | Oct 28 2025PATIENTS with advanced lung or skin cancer who received a COVID mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, according to US research published in Nature.
-
Beware potential rental pitfalls
Tuesday | Oct 28 2025BUYER and tenant advocate Paul Rowe shares some potential pitfalls to watch out for when leasing.
-
Mini-mise pain
Tuesday | Oct 28 2025MEDICHOICE’S new Ibuprofen Mini liquid capsules provide rapid pain relief in an easy-to-swallow format.
-
Want a role in medicine decisions?
Tuesday | Oct 28 2025THE Department of Health, Disability and Ageing is seeking expressions of interest from suitably qualified and experienced individuals – including pharmacists and pharmacologists – who would like to be considered for upcoming member vacancies on national health technology assessment (HTA) committees and sub-committees.
-
Back the bid
Tuesday | Oct 28 2025GLUCOJEL has teamed up with Netball Australia in its bid for the game’s inclusion at the Brisbane 2032 Olympics.
-
CKD PBS expansion for Jardiance
Tuesday | Oct 28 2025FROM 01 Nov, Jardiance (empagliflozin 10mg) will be listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of chronic kidney disease (CKD) in adults at moderate-to-severe risk of their condition worsening.
-
CSL hammered by low US vax rates
Tuesday | Oct 28 2025AT ITS AGM this morning, CSL announced it has downgraded its full-year profit and revenue outlook following lower-than-expected vaccination rates in the US and government cost-containment measures in China, which have reduced demand for albumin.
PARTNER SITES
to top